Julie V Selkirk Selected Research

3- aminotricyclo(2.2.1.02.6)heptane- 1,3- dicarboxylic acid

6/2005

Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julie V Selkirk Research Topics

Disease

4	Multiple Sclerosis 01/2022 - 01/2021
1	Ulcerative Colitis 01/2022
1	Inflammation (Inflammations) 12/2021
1	Body Weight (Weight, Body) 12/2021
1	Demyelinating Diseases (Demyelinating Disease) 12/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2021
1	Ischemia 06/2005

Drug/Important Bio-Agent (IBA)

4	ozanimodIBA 01/2022 - 01/2021
2	Sphingosine-1-Phosphate ReceptorsIBA 01/2022 - 12/2021
2	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2022 - 12/2021
1	Phosphates (Orthophosphate)IBA 12/2021
1	CuprizoneIBA 12/2021
1	Monoamine Oxidase (MAO)IBA 01/2021
1	3- aminotricyclo(2.2.1.02.6)heptane- 1,3- dicarboxylic acidIBA 06/2005
1	benzyloxyaspartate (TBOA)IBA 06/2005